Summary - SNY - NASDAQ - Weiss Ratings

C

Sanofi SNY

$50.05 -$0.53-1.05% NASDAQ

Recommendation

Prev Close

Volume

Avg Vol (90D)

Market Cap

Dividend & Yield

52-Week Range

$44.62 - $60.12

P/E (TTM)

EPS (TTM)

My Lists My Alerts

Access our Premium Ratings

Get Access

Rating

Reward

Risk

Rating Factors

Growth Index

Efficiency Index

Solvency Index

Total Return Index

Volatility Index

Dividend Index

Headlines

Analysts Can't Get Enough of These Little-Known Biopharma Stocks

6/12/2025 - MarketBeat

Nicholas Company Inc. Acquires 127,210 Shares of Sanofi $SNY

11/3/2025 - MarketBeat

Sanofi $SNY is Regal Partners Ltd's 6th Largest Position

11/3/2025 - MarketBeat

Novavax (NVAX): Valuation in Focus as Sanofi Takes Over Nuvaxovid and Milestone Payments Unlock

11/2/2025 - Simply Wall St

Hutchinson Financial Advisors INC Makes New Investment in Sanofi $SNY

11/2/2025 - MarketBeat

Hantz Financial Services Inc. Acquires 7,923 Shares of Sanofi $SNY

11/2/2025 - MarketBeat

Arkadios Wealth Advisors Raises Position in Sanofi $SNY

11/2/2025 - MarketBeat

Sanofi (NASDAQ:SNY) Given Average Rating of "Buy" by Analysts

11/2/2025 - MarketBeat

Sanofi's Efdoralprin Alfa Achieves Key Milestones in AATD Emphysema Study

10/31/2025 - TipRanks Financial Blog

The Bull Case For Novavax (NVAX) Could Change Following EU Vaccine Transfer Deal With Sanofi

10/31/2025 - Simply Wall St

Sanofi India Ltd (BOM:500674) Q3 2026 Earnings Call Highlights: Strategic Shifts and Financial Gains

10/30/2025 - GuruFocus

Q3 2026 Sanofi India Ltd Earnings Call Transcript

10/30/2025 - GuruFocus

Leerink Partnrs Issues Positive Estimate for Sanofi Earnings

10/30/2025 - MarketBeat

Pharma Giant Sanofi Chases 'The Miracles Of Science' In Corporate Campaign

10/29/2025 - MediaPost Marketing News

Sanofi's New Study on Balinatunfib: A Potential Game-Changer for IBD Treatment

10/29/2025 - TipRanks Financial Blog

Novavax (NVAX) Gains Momentum with Sanofi Deal and Analyst Endorsement

10/29/2025 - Yahoo! Finance: News

Sanofi India standalone net profit declines 7.54% in the September 2025 quarter

10/29/2025 - Business Standard - Markets & Investing

Y Intercept Hong Kong Ltd Takes $3.97 Million Position in Sanofi $SNY

10/29/2025 - MarketBeat

Envestnet Asset Management Inc. Has $165.95 Million Stock Holdings in Sanofi $SNY

10/29/2025 - MarketBeat

REGN Stock Up on Q3 Earnings Beat, Eylea HD Sales Increase

10/28/2025 - Zacks Investment Research

BioMarin Beats on Q3 Earnings, Seeks to Divest Hemophilia Gene Therapy

10/28/2025 - Zacks Investment Research

Sanofi extends agreement with Medidata on clinical trials

10/28/2025 - Seeking Alpha - Healthcare

Sanofi Successfully Prices $3 Billion Bond Issue

10/28/2025 - TipRanks Financial Blog

Compared to Estimates, Regeneron (REGN) Q3 Earnings: A Look at Key Metrics

10/28/2025 - Zacks Investment Research

Analysts Think These Stocks Could More Than Double in Value

5/23/2025 - MarketBeat

Income Statement

Total Revenue (TTM)

--

EBITDA (TTM)

--

EBIT (TTM)

--

Net Income (TTM)

--

Balance Sheet

Total Assets (Q)

Total Debt (Q)

Total Liabilities (Q)

Book Value Per Share (Q)

Cash Flow

Cash from Operations (TTM)

--

Cash from Investing (TTM)

--

Cash from Financing (TTM)

--

Net Change in Cash (TTM)

--

Filings

Filing Date

Thursday, July 31, 2025

Period Date

Monday, June 30, 2025

Next Filing

Week of Oct 20 and 24 (est)

Price History

Loading...

Beta

7-Day Total Return

30-Day Total Return

60-Day Total Return

90-Day Total Return

Year to Date Total Return

1-Year Total Return

2-Year Total Return

3-Year Total Return

5-Year Total Return

52-week Low

Sep 30, 2025 - $44.62

52-week High

Mar 10, 2025 - $60.12

Valuation

Market Cap

$122.94B - Large Cap

Enterprise Value

Price/Sales (TTM)

Price/Book (Q)

Dividends and Shares

Shares Outstanding

Dividend Per Share (Most Recent)

Dividend Per Share (TTM)

Corporate Info

Website

Phone Number

33 1 53 77 40 00

Address

46, avenue de la Grande Armée
Paris, 75017

Country

Year Founded

Business Description

Sector

--

Industry

--

Sanofi engages in the research, development, manufacture, and marketing of therapeutic solutions. It provides immunology and inflammation, rare diseases, neurology, oncology, and other medicines... more